Tag Archives: biopharmaceuticals

Access to Big Data

Emerging-Companies115x76

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the explosion of information about cellular activities and disease pathways happening today. With this explosion, the challenge for scientific database producers is to curate and process the published literature, small molecules, proteins, sequences and numeric data in ways Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

A Better Way to Make Unnatural Amino Acids Discovered by Yu

Make Unnatural Amino Acids

Certain amino acids that are not found in nature are highly sought after by pharmaceutical manufacturers. These “unnatural” amino acids have traditionally been very difficult to synthesize, so a new and improved technique for doing so is attracting a lot of attention. Amino acids are among the most basic components of living things. Long chains of them, translated from DNA, fold up to become proteins, some smaller groupings of amino acids form hormones, and a Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Nationwide Track and Trace System is Urgently Needed

Jim Greenwood

Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and regulations that allows criminals to enter markets with the lowest safety requirements to inject counterfeit, unsafe, and potentially lethal products into the national supply chain. The state-by-state system is both onerous and ineffective, and the risk it poses to public health from counterfeiters can no longer be ignored. In a recent opinion piece for Roll Call, I write that: “Congress Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact on their businesses, they must be ready to demonstrate the value of their products in ways that recognize the fine balance of cost and quality that ACO and ACO-like models seek to achieve. According to panelists speaking at the 2013 BIO International Convention session entitled, “Accountable Care Organization (ACO) Framework for Biopharmaceuticals,” there are three primary considerations when it comes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,